1713 related articles for article (PubMed ID: 21545096)
1. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
2. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Lammers T; Kiessling F; Hennink WE; Storm G
Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
[TBL] [Abstract][Full Text] [Related]
3. Personalized nanomedicine.
Lammers T; Rizzo LY; Storm G; Kiessling F
Clin Cancer Res; 2012 Sep; 18(18):4889-94. PubMed ID: 22829203
[TBL] [Abstract][Full Text] [Related]
4. Nanotheranostics for personalized medicine.
Mura S; Couvreur P
Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
Cabral H; Nishiyama N; Kataoka K
Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
[TBL] [Abstract][Full Text] [Related]
6. Image guided therapy: the advent of theranostic agents.
Terreno E; Uggeri F; Aime S
J Control Release; 2012 Jul; 161(2):328-37. PubMed ID: 22626940
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
9. Overcoming cellular multidrug resistance using classical nanomedicine formulations.
Kunjachan S; Błauż A; Möckel D; Theek B; Kiessling F; Etrych T; Ulbrich K; van Bloois L; Storm G; Bartosz G; Rychlik B; Lammers T
Eur J Pharm Sci; 2012 Mar; 45(4):421-8. PubMed ID: 21907796
[TBL] [Abstract][Full Text] [Related]
10. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
11. Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting.
Kunjachan S; Jayapaul J; Mertens ME; Storm G; Kiessling F; Lammers T
Curr Pharm Biotechnol; 2012 Mar; 13(4):609-22. PubMed ID: 22214503
[TBL] [Abstract][Full Text] [Related]
12. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
13. Self-assembling nanoclusters in living systems: application for integrated photothermal nanodiagnostics and nanotherapy.
Zharov VP; Kim JW; Curiel DT; Everts M
Nanomedicine; 2005 Dec; 1(4):326-45. PubMed ID: 17292107
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
Rizzo LY; Theek B; Storm G; Kiessling F; Lammers T
Curr Opin Biotechnol; 2013 Dec; 24(6):1159-66. PubMed ID: 23578464
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles for multimodal imaging and theragnosis.
Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
[TBL] [Abstract][Full Text] [Related]
16. Nano-graphene in biomedicine: theranostic applications.
Yang K; Feng L; Shi X; Liu Z
Chem Soc Rev; 2013 Jan; 42(2):530-47. PubMed ID: 23059655
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in basic and clinical nanomedicine.
Morrow KJ; Bawa R; Wei C
Med Clin North Am; 2007 Sep; 91(5):805-43. PubMed ID: 17826104
[TBL] [Abstract][Full Text] [Related]
18. Lanthanide-doped hollow nanomaterials as theranostic agents.
Kang X; Li C; Cheng Z; Ma P; Hou Z; Lin J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(1):80-101. PubMed ID: 24227795
[TBL] [Abstract][Full Text] [Related]
19. Combination of viral biology and nanotechnology: new applications in nanomedicine.
Saini V; Zharov VP; Brazel CS; Nikles DE; Johnson DT; Everts M
Nanomedicine; 2006 Sep; 2(3):200-6. PubMed ID: 17292143
[TBL] [Abstract][Full Text] [Related]
20. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
